Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-so-familiar routine of meetings, encrypted calls, and messages has, predictably, returned. But what can you do? The world keeps spinning, after all, so please join us as we fire up the coffee kettle to warm up a few cups of stimulation. Our choice today is white chocolate cranberry decadence, for those who track this sort of thing. Meanwhile, here are some tidbits to help you along. Hope all goes well and do stay in touch.

Republicans are set to accelerate Capitol Hill’s drug pricing chaos with a new proposal to lower the cost of prescription medicines, according to a summary document obtained by STAT. The effort is intended to compete with a Democratic package from House Speaker Nancy Pelosi that is expected to come up for a vote this week. The bill ignores the Pelosi bill’s most aggressive elements, such as allowing Medicare to directly negotiate the price of between 35 and 250 drugs and using an international benchmark to cap payments in the U.S.

Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

Your daily dose of news in health and medicine

Privacy Policy